COMMUNIQUÉS West-GlobeNewswire

Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
01/04/2026
New capability adds consultative support and strengthens Nephros’ broader water safety offering SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company [...]
J-Star Holding Announces Return of Jonathan Chiang as Chief Executive Officer
01/04/2026
TAICHUNG CITY, Taiwan, April 01, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse [...]
Roto-Rooter Completes Acquisitions for Two Significant Territories
01/04/2026
CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- On March 31, Roto-Rooter Services Company , a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE ) announced it has purchased the territory and assets of [...]
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
01/04/2026
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through [...]
Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health
01/04/2026
As approved peptide-based therapies gain broader adoption, Noom’s acquisition of Tailor Made Compounding—its first major acquisition—accelerates its expansion into healthy aging PRINCETON, N.J., April 01, 2026 (GLOBE [...]
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
01/04/2026
ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women [...]
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
01/04/2026
TORONTO and HAIFA, Israel, April 01, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a biotechnology company developing exosome-based therapies [...]
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
01/04/2026
ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in Frontiers [...]
A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month
01/04/2026
CHICAGO, April 01, 2026 (GLOBE NEWSWIRE) -- Often described as a “snowflake disease,” sarcoidosis can affect every patient differently, making it difficult to diagnose, treat, and even recognize. This April, the [...]
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
01/04/2026
International Cannabis Accelerates with 73% Net Revenue Growth and 100% Increase in Cannabis Flower Sales Volume Year-Over-Year Canadian Adult-Use and Medical Cannabis Net Revenue Combined Increased 8% Year-Over-Year; [...]
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
01/04/2026
Bezuclastinib NDA submitted under the FDA’s RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GIST Bezuclastinib combination [...]
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
01/04/2026
Financing reflects strong investor confidence and supports advancement of lead Type 1 Diabetes program ZURICH, Switzerland, April 01, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage [...]
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
01/04/2026
- Poster on previously shared positive results from DELIVER clinical trial in Duchenne muscular dystrophy (DMD) contextualizes observed clinical measures of functional improvement for managed care experts - - Two [...]
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
01/04/2026
BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Vireo Growth Inc. Announces Closing of Acquisition of Eaze Inc.
01/04/2026
Transaction expands Vireo’s operating footprint to 10 states with over 160 dispensaries and approximately 800,000 sq. ft. of cultivation and production Acquisition adds two new markets, California and Florida, and an [...]
VivoSim Announces Pricing of up to a $4 Million Public Offering
01/04/2026
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS), (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the [...]
Stryker to announce financial results for its first quarter of fiscal year 2026
01/04/2026
Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026. A press release will be [...]
RemoniHealth Expands Hardware-Free "Vision-as-a-Service" Platform to Cover Over 90% of Chronic Eye Diseases
01/04/2026
Exclusive licensing of new breakthrough, clinic-grade tests to the RemoniHealth platform, solidifies its position as the only integrated RPM and PCM solution for population eye health NEW YORK, April 01, 2026 (GLOBE [...]
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
01/04/2026
FRISCO, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution specialty [...]

Pages